Connor, Clark & Lunn Investment Management (CC&L)
SVRA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Savara SVRA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Sell
74,876
-47,986
-39% -$258K ﹤0.01% 1407
2026
Q1 		$671K Buy
122,862
+47,980
+64% +$267K ﹤0.01% 1251
2025
Q4 		$452K Sell
74,882
-18,985
-20% -$93K ﹤0.01% 1325
2025
Q3 		$335K Sell
93,867
-215,968
-70% -$639K ﹤0.01% 1342
2025
Q2 		$706K Sell
309,835
-469,119
-60% -$1.28M ﹤0.01% 1150
2025
Q1 		$2.16M Sell
778,954
-58,513
-7% -$162K 0.01% 709
2024
Q4 		$2.57M Buy
837,467
+146,858
+21% +$512K 0.01% 661
2024
Q3 		$2.93M Buy
690,609
+242,249
+54% +$1.07M 0.01% 579
2024
Q2 		$1.81M Buy
448,360
+55,637
+14% +$248K 0.01% 680
2024
Q1 		$1.96M Buy
392,723
+124,276
+46% +$600K 0.01% 675
2023
Q4 		$1.26M Buy
268,447
+42,218
+19% +$162K 0.01% 792
2023
Q3 		$855K Sell
226,229
-13,428
-6% -$47.9K ﹤0.01% 864
2023
Q2 		$766K Buy
239,657
+32,011
+15% +$75.2K ﹤0.01% 874
2023
Q1 		$405K Buy
207,646
+32,573
+19% +$73.4K ﹤0.01% 940
2022
Q4 		$271K Buy
175,073
+3,158
+2% +$4.33K ﹤0.01% 991
2022
Q3 		$266K Buy
171,915
+27,483
+19% +$44.2K ﹤0.01% 939
2022
Q2 		$220K Buy
144,432
+9,363
+7% +$12.3K ﹤0.01% 914
2022
Q1 		$177K Sell
135,069
-16,330
-11% -$19.7K ﹤0.01% 954
2021
Q4 		$188K Sell
151,399
-12,146
-7% -$14.5K ﹤0.01% 987
2021
Q3 		$226K Buy
163,545
+19,963
+14% +$27K ﹤0.01% 930
2021
Q2 		$244K Buy
143,582
+107,954
+303% +$194K ﹤0.01% 888
2021
Q1 		$74K Buy
+35,628
New +$61K ﹤0.01% 953

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SVRA Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Savara (SVRA) stake by 39% in Q2 2026, selling an estimated $258K and leaving 74,876 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SVRA in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.93M in Q3 2024. 181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 74,876 shares of Savara worth $461K as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 47,986 Savara shares in Q2 2026, an estimated $258K.
  • Savara made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1407 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Savara in Q1 2021 and has held it in 22 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Savara position peaked at $2.93M in Q3 2024.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.